Judge Neil Gorsuch Confirmed by Senate
Gorsuch on SCOTUS: likely to influence many health policies.
Read More
High Cholesterol Drug Advances
Breakthrough status for a new drug to treat familial hypercholesterolemia.
Huntington's Drug Approved for Symptom Treatment
A drug to help Huntington's symptoms got the FDA's nod.
Diabetes Drug Choice: No Easy Algorithms
Physicians have more choices than guidance in picking diabetes drugs.
More than Half of Physicians Feel Burned Out: ACP Offers Remedies
Medicine can be exhausting.Tips on avoiding burnout.
Sanjay Saint, MD: Why Are CAUTI Still Common?
Indwelling catheters are over-used, expert says.
Rising Drug Prices: What's Behind Them?
Can anything halt runaway drug prices? ACP asks.
Salahuddin Kazi, MD: Drugs, Strategies, Therapies in Rheumatology, MD
Noted rheumatologist reviews research.
ACA Fight: It's Far from Over ACP Officials Say
The Affordable Care Act is still under attack, according to the ACP.
Hepatitis C Care: It's Cookbook Medicine, Expert Tells Physicians
Hepatitis C care often doesn't require a specialist.
ACP: Blueprint for Substance Use Prevention and Treatment
Physicians can play a role in curbing substance misuse.
Zika Vaccine Enters Phase 2 Trial
NIAID's director announced progress in developing a Zika vaccine.
Poor Diet a Factor in Kids' ADHD
Diets high in sugar and saturated fat are associated with ADHD.
In Case You Missed It: ACC Scientific Sessions 2017 Wrap Up
THe ACC's meeting offered studies likelcc200y to impact clinical practice.
SUMMIT-07 Study Favorable for New Opioid Candidate
Nektar Therapeutics announced favorable phase 3 results for NKTR-181.
Heart Damage Common After Any Surgery; Test Could Detect It
Heart damage after non-cardiac surgery is usually missed. A test finds it.
Digoxin Linked to High Risk of Sudden Death in AFib
In patients with AFib, digoxin should not be a first-line drug.
TAVR Appears to Pose Cognition Risk through Microbleeds
Microbleeds in the brain appear to increase with cardiac procedures:Study.
Rivaroxaban Beats Aspirin in VTE Prevention
In the first head to head trial, rivaroxaban was more effective than aspirin.
Disappointing Results for HDL-C Therapy
A synthetic version of "good" cholesterol failed to clear blocked arteries.
Antiplatelet Therapy: Rivaroxaban No Riskier than Aspirin
Bleeding complications with rivaroxaban no worse than with aspirin.
PCSK9 Drug Did Not Impact Cognition, Study Found
Study: no worries about cognition loss with PCSK9s.
FDA Warning on Absorbable Stent, Researchers Blame User Error
The Absorb GT1 Bioresorbable Vascular Stent raised concerns at the FDA.
Drugs Work As Well As Interventions in Patients with CTO: Study
Drugs were as effective in CTO patients as PCI, Korean study found.
Stenting: New Diagnostic Tool Assesses Need without Patient Discomfort
New diagnostic tool iFR is less painful for heart patients than FFR.
FOURIER Trial Shows Significant Risk Reduction for Cardiovascular Events
In a large, long-term clinical trial evolocumab reduced heart risk.
TAVR Again Found As Good as Surgery
In another major study comparing TAVR to surgery, outcomes were similar.
Stem Cell Eye Injections for AMD Led to Blindness, NEJM Reports
Mishaps show stem cell clinics need regulation, journal says.
Mixed Results for Bococizumab in PCSK9 Inhibition
Details on why Pfizer pulled its PCSK9 inhibitor seen in SPIRE studies.
FDA Advisory Committees Want Restrictions on Oxymorphone Hydrochloride ER
A panel wants the FDA to restrict an opioid because abusers are injecting it.